ILAN ANATOLE KERMAN
Medical Practice in Ann Arbor, MI
License number
Michigan 4301079666
Issued Date
Jun 20, 2002
Expiration Date
Jun 30, 2003
Category
Medicine
Type
Medical Doctor - Educational Limited
Address
Address
Ann Arbor, MI 48109
Personal information
See more information about ILAN ANATOLE KERMAN at radaris.comName
Address
Phone
1024 Island Drive Ct, Ann Arbor, MI 48105
5580 Plymouth Rd, Ann Arbor, MI 48105
Professional information
See more information about ILAN ANATOLE KERMAN at trustoria.com
Snp Detection And Other Methods For Characterizing And Treating Bipolar Disorder And Other Ailments
Snp Detection And Other Methods For Characterizing And Treating Bipolar Disorder And Other Ailments
US Patent:
2008019, Aug 21, 2008
Filed:
Oct 5, 2007
Appl. No.:
11/868456
Inventors:
Huda Akil - Ann Arbor MI, US
Stanley J. Watson - Ann Arbor MI, US
Simon J. Evans - Milan MI, US
Cortney Turner - Ann Arbor MI, US
Rene Bernard - Ann Arbor MI, US
Ilan Kerman - Ann Arbor MI, US
Robert Thompson - Ann Arbor MI, US
Margit Burmeister - Ann Arbor MI, US
Laura J. Scott - Ann Arbor MI, US
Fan Meng - Ann Arbor MI, US
Michael Boehnke - Ann Arbor MI, US
William Bunney - Laguna Beach CA, US
Marquis Vawter - Laguna Niguel CA, US
Edward Jones - Winters CA, US
Prabhakara V. Choudary - Davis CA, US
Richard Myers - Stanford CA, US
Alan Schatzberg - Los Altos CA, US
Jun Li - Ann Arbor MI, US
Devin Absher - San Francisco CA, US
Stanley J. Watson - Ann Arbor MI, US
Simon J. Evans - Milan MI, US
Cortney Turner - Ann Arbor MI, US
Rene Bernard - Ann Arbor MI, US
Ilan Kerman - Ann Arbor MI, US
Robert Thompson - Ann Arbor MI, US
Margit Burmeister - Ann Arbor MI, US
Laura J. Scott - Ann Arbor MI, US
Fan Meng - Ann Arbor MI, US
Michael Boehnke - Ann Arbor MI, US
William Bunney - Laguna Beach CA, US
Marquis Vawter - Laguna Niguel CA, US
Edward Jones - Winters CA, US
Prabhakara V. Choudary - Davis CA, US
Richard Myers - Stanford CA, US
Alan Schatzberg - Los Altos CA, US
Jun Li - Ann Arbor MI, US
Devin Absher - San Francisco CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Stanford CA
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present application relates to the use of SNPs and differential exon expression to characterize, diagnose or treat bipolar disorder and other mental illnesses, such as major depressive disorder and schizophrenia.
Snp Detection And Other Methods For Characterizing And Treating Bipolar Disorder And Other Ailments
Snp Detection And Other Methods For Characterizing And Treating Bipolar Disorder And Other Ailments
US Patent:
2011010, May 5, 2011
Filed:
Apr 20, 2010
Appl. No.:
12/764023
Inventors:
HUDA AKIL - ANN ARBOR MI, US
STANLEY J. WATSON - ANN ARBOR MI, US
SIMON J. EVANS - MILAN MI, US
CORTNEY TURNER - ANN ARBOR MI, US
RENE BERNARD - ANN ARBOR MI, US
ILAN KERMAN - ANN ARBOR MI, US
ROBERT THOMPSON - ANN ARBOR MI, US
MARGIT BURMEISTER - ANN ARBOR MI, US
LAURA J. SCOTT - ANN ARBOR MI, US
FAN MENG - ANN ARBOR MI, US
MICHAEL BOEHNKE - ANN ARBOR MI, US
WILLIAM BUNNEY - LAGUNA BEACH CA, US
MARQUIS VAWTER - LAGUNA NIGUEL CA, US
EDWARD JONES - WINTERS CA, US
PRABHAKARA V. CHOUDARY - DAVIS CA, US
RICHARD MYERS - STANFORD CA, US
ALAN SCHATZBERG - LOS ALTOS CA, US
JUN LI - ANN ARBOR MI, US
DEVIN ABSHER - SAN FRANCISCO CA, US
STANLEY J. WATSON - ANN ARBOR MI, US
SIMON J. EVANS - MILAN MI, US
CORTNEY TURNER - ANN ARBOR MI, US
RENE BERNARD - ANN ARBOR MI, US
ILAN KERMAN - ANN ARBOR MI, US
ROBERT THOMPSON - ANN ARBOR MI, US
MARGIT BURMEISTER - ANN ARBOR MI, US
LAURA J. SCOTT - ANN ARBOR MI, US
FAN MENG - ANN ARBOR MI, US
MICHAEL BOEHNKE - ANN ARBOR MI, US
WILLIAM BUNNEY - LAGUNA BEACH CA, US
MARQUIS VAWTER - LAGUNA NIGUEL CA, US
EDWARD JONES - WINTERS CA, US
PRABHAKARA V. CHOUDARY - DAVIS CA, US
RICHARD MYERS - STANFORD CA, US
ALAN SCHATZBERG - LOS ALTOS CA, US
JUN LI - ANN ARBOR MI, US
DEVIN ABSHER - SAN FRANCISCO CA, US
Assignee:
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY - STANFORD CA
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present application relates to the use of SNPs and differential exon expression to characterize, diagnose or treat bipolar disorder and other mental illnesses, such as major depressive disorder and schizophrenia.
Fgf2-Related Methods For Diagnosing And Treating Depression
Fgf2-Related Methods For Diagnosing And Treating Depression
US Patent:
2009023, Sep 17, 2009
Filed:
Nov 13, 2006
Appl. No.:
12/093437
Inventors:
Huda Akil - Ann Arbor MI, US
Stanley J. Watson - Ann Arbor MI, US
Simon J. Evans - Milan MI, US
Cortney Turner - Belleville MI, US
Rene Bernard - Ann Arbor MI, US
Ilan Kerman - Ann Arbor MI, US
Robert C. Thompson - Ann Arbor MI, US
Margit Burmeister - Ann Arbor MI, US
Laura J. Scott - Ann Arbor MI, US
Fan Meng - Ann Arbor MI, US
Michael Boehnke - Ann Arbor MI, US
Marquis P. Vawter - Laguna Nigel CA, US
Edward G. Jones - Winters CA, US
Prabhakara V. Choudary - Davis CA, US
Richard M. Myers - Stanford CA, US
Alan F. Schatzberg - Los Altos CA, US
Jun Li - Palo Alto CA, US
Devin Absher - San Francisco CA, US
Hiroaki Tomita - Irvine CA, US
Stanley J. Watson - Ann Arbor MI, US
Simon J. Evans - Milan MI, US
Cortney Turner - Belleville MI, US
Rene Bernard - Ann Arbor MI, US
Ilan Kerman - Ann Arbor MI, US
Robert C. Thompson - Ann Arbor MI, US
Margit Burmeister - Ann Arbor MI, US
Laura J. Scott - Ann Arbor MI, US
Fan Meng - Ann Arbor MI, US
Michael Boehnke - Ann Arbor MI, US
Marquis P. Vawter - Laguna Nigel CA, US
Edward G. Jones - Winters CA, US
Prabhakara V. Choudary - Davis CA, US
Richard M. Myers - Stanford CA, US
Alan F. Schatzberg - Los Altos CA, US
Jun Li - Palo Alto CA, US
Devin Absher - San Francisco CA, US
Hiroaki Tomita - Irvine CA, US
Assignee:
Prtzker Neuropsychiatric Research Fund LLC - Chicago IL
International Classification:
A61K 38/00, C12Q 1/68
US Classification:
514 2, 435 6
Abstract:
The present application relates to the treatment and diagnosis of mood disorders, including bipolar disorder, major depression disorder and schizophrenia. The invention provides novel diagnostic markers and assays, as well as research tools for the development and discovery of agents and compounds which are useful for treating patients who suffer from mental illness.
Fgf2-Related Methods For Diagnosing And Treating Depression
Fgf2-Related Methods For Diagnosing And Treating Depression
US Patent:
2009001, Jan 15, 2009
Filed:
Nov 13, 2006
Appl. No.:
11/559398
Inventors:
Huda Akil - Ann Arbor MI, US
Stanley Watson - Ann Arbor MI, US
Simon Evans - Milan MI, US
Cortney Turner - Ann Arbor MI, US
Rene Bernard - Ann Arbor MI, US
Ilan Kerman - Ann Arbor MI, US
Robert C. Thompson - Ann Arbor MI, US
Margit Burmeister - Ann Arbor MI, US
Laura J. Scott - Ann Arbor MI, US
Fan Meng - Ann Arbor MI, US
Michael Boehnke - Ann Arbor MI, US
William Bunney - Laguna Beach CA, US
Marquis Vawter - Laguna Niguel CA, US
Edward Jones - Winters CA, US
Prabhakara Choudary - Davis CA, US
Richard Myers - Stanford CA, US
Alan Schatzberg - Los Altos CA, US
Jun Li - Palo Alto CA, US
Devin Absher - San Francisco CA, US
Hiroaki Tomita - Irvine CA, US
Stanley Watson - Ann Arbor MI, US
Simon Evans - Milan MI, US
Cortney Turner - Ann Arbor MI, US
Rene Bernard - Ann Arbor MI, US
Ilan Kerman - Ann Arbor MI, US
Robert C. Thompson - Ann Arbor MI, US
Margit Burmeister - Ann Arbor MI, US
Laura J. Scott - Ann Arbor MI, US
Fan Meng - Ann Arbor MI, US
Michael Boehnke - Ann Arbor MI, US
William Bunney - Laguna Beach CA, US
Marquis Vawter - Laguna Niguel CA, US
Edward Jones - Winters CA, US
Prabhakara Choudary - Davis CA, US
Richard Myers - Stanford CA, US
Alan Schatzberg - Los Altos CA, US
Jun Li - Palo Alto CA, US
Devin Absher - San Francisco CA, US
Hiroaki Tomita - Irvine CA, US
International Classification:
A01K 67/00, C12Q 1/68, C12Q 1/02, G01N 33/68, A61K 38/17
US Classification:
800 8, 435 6, 435 29, 436 86, 514 12
Abstract:
The present application relates to the treatment and diagnosis of mood disorders, including bipolar disorder, major depression disorder and schizophrenia. The invention provides novel diagnostic markers and assays, as well as research tools for the development and discovery of agents and compounds which are useful for treating patients who suffer from mental illness.